Dipeptidyl Peptidase-4 inhibitors use in type II diabetic patients in a tertiary hospital

• Ngā kaituhi matua: Woh Yon Mak (Author), Jivanraj R. Nagarajah (Author), Hannah Abdul Halim (Author), Anitha Ramadas (Author), Zulsairi Mohd Pauzi (Author), Lay Ting Pee (Author), Nirmala Jagan (Author)
• Hōputu: Pukapuka
• I whakaputaina: Taylor & Francis Group, 2020-12-01T00:00:00Z.
• Ngā marau: article
• Urunga tuihono: Connect to this object online.

Background In Malaysia, for more than a decade, dipeptidyl peptidase-4 inhibitors (DPP-4i) are among the oral antidiabetic medications used as monotherapy or in combination to manage type II diabetes mellitus (T2DM). These medications are known for the efficacy in glycated haemoglobin (HbA1c) reduct...